5 strategies for biotech startups to outlast a market downturn
TechCrunch
MARCH 16, 2023
James Coates is the Health and Human Performance principal at Decisive Point , a venture capital and advisory firm that invests in and supports startups with emerging defense technologies. Inflationary market dynamics and ongoing fiscal tightening continue to pose significant risks to capital commitments.
Let's personalize your content